We are live on ! Find out more
ETNB

89bio

Delisted

ETNB was delisted on the 29th of October, 2025.

2 hedge funds and large institutions have $1.11M invested in 89bio in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 192 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 1982 (-196)

100% less capital invested

Capital invested by funds: $2.27B → $1.11M (-$2.27B)

100% less funds holding in top 10

Funds holding in top 10: 110 (-11)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 192

104.24% less ownership

Funds ownership: 104.3%0.06% (-104%)

Holders
2
Holders Change
-196
Holders Change %
-98.99%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
-11
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
192
Calls
Puts
Net Calls
Net Calls Change

ETNB Hedge Fund Activity: Q4 2025 in Review

2 of the 8,226 institutional investors tracked by Wall St. Rank reported a position in 89bio (ETNB) for Q4 2025, worth a combined $1.11M — down 100% from $2.27B a quarter earlier.

Sellers outnumbered buyers: 192 funds closed out of ETNB and 0 opened new positions — a net loss of 192 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RA Capital Management, exiting entirely with an estimated $292M sold.

  • 2 institutional investors held 89bio (ETNB) as of Q4 2025, down from 198 in Q3 2025.
  • Funds reported $1.11M of 89bio stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new 89bio positions in Q4 2025 and 192 closed out, a net change of -192 holders.
  • The largest 89bio seller in Q4 2025 was RA Capital Management, an estimated $292M sold.

Based on aggregated 13F filings for Q4 2025.